<DOC>
	<DOCNO>NCT02290717</DOCNO>
	<brief_summary>Rationale : Vitiligo common skin disorder impair patient 's quality life . Many depigmented lesion vitiligo patient remain therapy resistant medical treatment . Therefore new therapeutic option patient necessary . Currently , dermabrasion conventional fractional laser therapy combination NB-UVB therapy steroid appear effective therapy resistant area . However , little literature combination available . Objectives : To assess efficacy patient safety ( 1 ) fractional CO2-laser treatment combination NB- UVB , ( 2 ) fractional CO2-laser treatment combination NB- UVB topical corticosteroid versus NB-UVB treatment alone ( 3 ) Study design : Prospective observer blind randomise intra-patient control study . Study population : 23 patient â‰¥ 18 year non segmental vitiligo receive NB-UVB treatment Netherlands Institute Pigment Disorders ( SNIP ) Academic Medical Centre University Amsterdam . We include patient 3 depigmented lesion resistant NB- UVB treatment 3 6 month . Methods : Three NB-UVB resistant depigmented region trunk extremity randomly allocate ; ( 1 ) NB-UVB treatment combination fractional CO2 laser abrasion , ( 2 ) NB-UVB treatment combination fractional CO2 laser abrasion topical steroid , ( 3 ) NB-UVB treatment alone . NB-UVB treatment topical steroid give accord standard treatment protocol SNIP continue least 6 month . Two 6 month laser treatment , percentage repigmentation lesion assess .</brief_summary>
	<brief_title>Fractional Laser Combination With UVB Therapy Vitiligo Patients</brief_title>
	<detailed_description />
	<mesh_term>Vitiligo</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Inclusion criterion Patients non segmental ( generalise ) vitiligo visit Netherlands Institute Pigment Disorders receive NB UVB treatment 3 6 month Age &gt; 18 year At least 3 therapy resistant vitiligo lesion extremities trunk large 5x5 cm one vitiligo lesion extremity trunk least 5x15 cm . Patient willing able give write informed consent Exclusion criterion Skin type I Recurrent HSV skin infection Hypertrophic scar Keloid Cardial insufficiency Patients pregnant breastfeeding Patients competent understand procedure involve Patients personal history melanoma nonmelanoma skin cancer Patients atypical nevus .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>ultraviolet therapy</keyword>
	<keyword>non segmental</keyword>
	<keyword>vitiligo</keyword>
	<keyword>topical corticosteroid</keyword>
	<keyword>laser</keyword>
	<keyword>fractional</keyword>
	<keyword>CO2</keyword>
	<keyword>carbon dioxide</keyword>
	<keyword>UVB</keyword>
</DOC>